SCHEMBL6073436

SCHEMBL6073436

Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc([AsH2])c34)cc2)c1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 20/20 0.79
FLT3 P36888 15/20 0.79
KIT P10721 13/20 0.79
CSF1R P07333 9/20 0.79
FLT4 P35916 9/20 0.79
FLT1 P17948 8/20 0.79
LYN P07948 6/20 0.79
SRC P12931 5/20 0.79
BLK P51451 5/20 0.79
PLK4 O00444 4/20 0.79
AURKA O14965 4/20 0.79
ROCK2 O75116 4/20 0.79
MET P08581 4/20 0.79
PRKACA P17612 4/20 0.79
RPS6KB1 P23443 4/20 0.79
CSNK1D P48730 4/20 0.79
STK3 Q13188 4/20 0.79
ROCK1 Q13464 4/20 0.79
MARK2 Q7KZI7 4/20 0.79
AURKB Q96GD4 4/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Linifanib SCHEMBL93804 0.89 KDR (1.00) KDRFLT3KITCSF1RFLT4
Linifanib SCHEMBL29375368 0.89 KDR (1.00) KDRFLT3KITCSF1RFLT4
Linifanib SCHEMBL1880038 0.88 KDR (0.98) KDRFLT3KITCSF1RFLT4
Linifanib SCHEMBL2239943 0.86 KDR (0.94) KDRFLT3KITCSF1RFLT4
SCHEMBL25874674 0.84 KDR (0.73) KDRFLT3KITCSF1RFLT4
SCHEMBL25779641 0.82 KDR (0.70) KDRFLT3KITCSF1RFLT4
SCHEMBL30501550 0.82 KDR (0.74) KDRFLT3KITCSF1RFLT4
SCHEMBL4092755 0.82 KDR (0.74) KDRFLT3KITCSF1RFLT4
SCHEMBL3396622 0.80 KDR (0.77) KDRFLT3KITCSF1RFLT4
SCHEMBL25874656 0.80 KDR (0.68) KDRFLT3KITCSF1RFLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006034234-A1 CRYSTALLINE FORM 3 OF ATRASENTAN HYDROCHLORIDE ABBOTT LABORATORIES (US) 2006-03-30 WO disclosed